Hint mode is switched on Switch off

KalVista Pharmaceuticals, ordinary share
KALV, US4834971032

Add a stock to WL
Choose all Reset all
KalVista Pharmaceuticals, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

  • Issuer
  • Full borrower / issuer name
    KalVista Pharmaceuticals, Inc.
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    KALV
  • Placement
    07.09.2018
  • Lock up period
    180
  • Number of papers
    4,000,000
  • Volume of raised funds
    68 mln USD
  • Placement share
    27.03%
  • Final placement price
    17 USD
  • Price change since placement date
    58.76%
  • By capitalization
    251.6 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    KALV
  • Placement
    09.02.2021
  • Lock up period
    180
  • Number of papers
    4,500,000
  • Volume of raised funds
    70.25 mln USD
  • Final placement price
    15.61 USD
  • Price change since placement date
    72.9%
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    KALV
  • Placement
    27.12.2022
  • Lock up period
    180
  • Number of papers
    34,102,349
  • Volume of raised funds
    56.91 mln USD
  • Placement share
    27.81%
  • Final placement price
    6 USD
  • Price change since placement date
    349.83%
  • By capitalization
    204.61 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    KALV
  • Placement
    04.11.2024
  • Lock up period
    180
  • Number of papers
    5,500,000
  • Volume of raised funds
    55 mln USD
  • Placement share
    11.21%
  • Final placement price
    10 USD
  • Price change since placement date
    169.9%
  • By capitalization
    490.82 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2025
I q eng
II q eng
III q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
2015
I q eng
II q eng
III q eng
IV q eng
Show all Hide

Related Stock indices

Indicators

News

30/04/2026 KalVista Pharmaceuticals (NASDAQ:KALV) Acquired by Chiesi Group in Strategic Rare Disease Expansion
30/04/2026 Market Movers: Rising Dragon Acquisition Corp. (NASDAQ: RDAC) Leads Today's Top Stock Gainers
30/04/2026 KalVista Pharmaceuticals (NASDAQ: KALV) Downgraded by Citigroup Amid Acquisition and EKTERLY's Strong Launch
29/04/2026 KalVista Pharmaceuticals: Entry Into A Material Definitive Agreement, Regulation Fd Disclosure, Financial Statements And Exhibits
25/03/2026 KalVista Pharmaceuticals Reports Eight Months Fiscal Year 2025 Financial Results and Provides Corporate Update
All organization news

Domestic and international bonds of the issuer

Holders

Industry Leaders

Registration is required to get access.